Lupus Nephritis

Therapeutic drug monitoring of mycophenolic acid and clinical outcomes of lupus nephritis: a systematic review and meta-analysis
Thunyatorn Wuttiputhanun, Nuanjanthip Naiyarakseree, Suwasin Udomkarnjananun, Wonngarm Kittanamongkolchai, Leelahavanichkul Asada, Pajaree Chariyavilaskul, Natavudh Townamchai, Yingyos Avihingsanon

Lupus Science & Medicine Jan 2024, 11 (1) e001093; DOI: 10.1136/lupus-2023-001093
Fragility of randomised controlled trials for systemic lupus erythematosus and lupus nephritis therapies
Gabriel Figueroa-Parra, Michael S Putman, Cynthia S Crowson, Alí Duarte-García

Lupus Science & Medicine Jan 2024, 11 (1) e001068; DOI: 10.1136/lupus-2023-001068
Circulating neutrophil extracellular trap remnants as a biomarker to predict outcomes in lupus nephritis
Laura Patricia Whittall-Garcia, Farnoosh Naderinabi, Dafna D Gladman, Murray Urowitz, Zahi Touma, Ana Konvalinka, Joan Wither

Lupus Science & Medicine Jan 2024, 11 (1) e001038; DOI: 10.1136/lupus-2023-001038
LP-099 High genetic risk loads increase the risk of lupus nephritis in Koreans
Young-Chang Kwon, Eunji Ha, Hyuk-Hee Kwon, Dae Jin Park, Jung-Min Shin, Young Bin Joo, Won Tae Chung, Dae-Hyun Yoo, Hye-Soon Lee, Kwangwoo Kim, Sang-Cheol Bae, So-Young Bang

Lupus Science & Medicine Jul 2023, 10 (Suppl 1) A126; DOI: 10.1136/lupus-2023-KCR.204
LP-128 Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and azathioprine as maintenance therapies for lupus nephritis: a network meta-analysis
Young Ho Lee, Gwan Gyu Song

Lupus Science & Medicine Jul 2023, 10 (Suppl 1) A134; DOI: 10.1136/lupus-2023-KCR.220
LP-133 Baseline clinical characteristics of SLE patients compared to those with lupus nephritis and on renal replacement treatment (RRT) including kidney transplantation
Rajaie Namas, Sarah Al Qassimi, Amir Malik, Muriel Ghosn, Lara Memisoglu, Hani Shatnawi, Mohamed Elarabi, Nizar Attallah

Lupus Science & Medicine Jul 2023, 10 (Suppl 1) A136-A137; DOI: 10.1136/lupus-2023-KCR.223
LP-207 Impact of time to remission, flares and time on immunosuppressives on the estimated glomerular filtration rate in lupus nephritis
Konstantinos Tselios, Dafna Gladman, Jiandong Su, Murray Urowitz

Lupus Science & Medicine Jul 2023, 10 (Suppl 1) A137-A138; DOI: 10.1136/lupus-2023-KCR.224
LP-135 High neutrophil-to-lymphocyte ratio is a risk factor for chronic kidney disease in patients with lupus nephritis
Dong-Jin Park, Hyemin Jeong, Sung-Eun Choi, Ji-Hyoun Kang, Shin-Seok Lee

Lupus Science & Medicine Jul 2023, 10 (Suppl 1) A139; DOI: 10.1136/lupus-2023-KCR.226
LO-017 Zetomipzomib (KZR-616) demonstrates anti-inflammatory and immunomodulatory potential in patients with active lupus with or without lupus nephritis: results from the open-label Phase 1b/2 MISSION study
Brad Rovin, Amit Saxena, Richard Leff, Elaine Li, Eunmi Park, Noreen Henig

Lupus Science & Medicine Jul 2023, 10 (Suppl 1) A14-A16; DOI: 10.1136/lupus-2023-KCR.17
LO-032 Increased IFITM gene-signatures in age-associated B and plasma cells define non-response to mycophenolate mofetil in systemic lupus erythematosus
Raul Lopez-Dominguez, Juan Antonio Villatoro-Garcia, Concepcion Marañon, Daniel Goldman, Michelle Petri, Pedro Carmona-Saez, Marta Alarcon-Riquelme, Daniel Toro-Domínguez

Lupus Science & Medicine Jul 2023, 10 (Suppl 1) A26-A27; DOI: 10.1136/lupus-2023-KCR.33

Main menu

Lupus Nephritis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Lupus Nephritis

Pages